Measurement of obesity by anthropometry and bioelectric impedance analysis: Correlation with fasting lipids and insulin resistance in an Asian population

Annals of the Academy of Medicine Singapore

Volumn 28, Issue 3, 1999, Pages 445-450

  Tai, E S ^a   Ho, S C ^b   Fok, A C K ^b   Tan, C E ^b  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b NONE

Author keywords

Body mass index; Chinese; Coronary artery disease risk; Waist circumference; Waist hip ratio

Indexed keywords

LIPID;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD; BODY COMPOSITION; CHINA; COMPARATIVE STUDY; DIET RESTRICTION; ETHNOLOGY; FEMALE; HUMAN; IMPEDANCE; INSULIN RESISTANCE; MALE; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PHYSIOLOGY; PROGNOSIS; RISK FACTOR; SEXUAL DEVELOPMENT; SINGAPORE;

ADULT; ANTHROPOMETRY; BODY COMPOSITION; CHINA; ELECTRIC IMPEDANCE; FASTING; FEMALE; HUMANS; INSULIN RESISTANCE; LIPIDS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PROGNOSIS; RISK FACTORS; SEX CHARACTERISTICS; SINGAPORE;

EID: 0033128181     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Hubert H B, Feinleib M, McNamara P M, Castelli W P. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67:968-77.
2. Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Bjornthorp P, Tibblin G. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13-year follow-up of participants in the study of men born in 1913. BMJ 1984; 289:1401-4.
3. Kissebah AH, Vydelingum N, Murray R, Evans D J, Hartz A J, Kalkhoff R K, et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1984; 54:254-60.
4. Lindahl B, Asplund K, Hallmans G. High serum insulin, insulin resistance and their associations with cardiovascular risk factors. The Northern Sweden MONICA Population Study. J Inter Med 1993; 234:263-70.
5. Kissebah A H, Freedman D S, Peiris A N. Health risks of obesity. Med Clin North Am 1989; 73:111-38.
6. Kahn H S, Austin H, Williamson D F, Arensberg D. Simple anthropometric indices associated with ischemic heart disease. J Clin Epidemiol 1996; 49:1017-24.
7. Kannel W B, Cupples L A, Raaswami R, Stokes J, Kreger B E, Higgins M. Regional adiposity and risk of cardiovascular disease; The Framingham Study. J Clin Epidemiol 1991; 44:183-90.
8. Lapidus L, Bengtsson C, Larsson B. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. BMJ 1984; 289:1257-61.
9. Karter A J, Mayer Davis E J, Selby J V, D'Agostino R B J, Haffner S M, Sholinsky P, et al. Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women. The insulin resistance and atherosclerosis study. Diabetes 1996; 45:1547-55.
10. Seidell J C, Cigolini M, Charzewska J, Ellsinger B M, Di Biase G, Bjornthorp P, et al. Indicators of fat distribution, serum lipids, and blood pressure in European women born in 1948. Am J Epidemiol 1989; 130:53-65.
11. Campos H, Bailey S M, Gussak L S, Sues X, Orvados M, Schaefer E J. Relations of body habitus, fitness level, and cardiovascular risk factors including lipoproteins and apolipoproteins in a rural and urban Costa Rican population. Arterioscler Thromb Vase Biol 1991; 11:1077-88.
12. Lukaski H C, Johnson P E, Bolonchuk W W, Lykken G I. Assessment of fat-free mass using bioelectric impedance measurement of the human body. Am J Clin Nutr 1985; 41:410-4.
13. Matthews D R, Hosker J P, Rudenski A S, Naylor B A, Treacher D F, Turner R C. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-9.
14. Reaven G. Role of insulin resistance in human disease. Diabetes 1988; 37:1595-607.
15. Abate N, Garg A, Peshock R M, Stray-Gendersen J, Grundy S M. Relationship of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest 1995; 96:88-98.
16. Bonadonna R C, Groop L, Kraemer N, Ferrennini E, Del Prato S, Defrozo R A. Obesity and insulin resistance in humans: a dose-response study. Metabolism 1990; 39:452-9.
17. Yki-Jarvinen H, Koivisto V A. Effects of body composition on insulin sensitivity. Diabetes 1983; 32:965-9.
18. Bogardus C, Lilloja S, Mott D M, Hollenbeck C, Reaven G. Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol 1985; 248:286-91.
19. Nagulesparan M, Savage P J, Unger R H, Bennet P H. A simplified method using somatostatin to assess in vivo insulin resistance over a range of obesity. Diabetes 1979; 28:980-3.
20. Haffner S M, Kennedy E, Gonzalez C, Stern M P, Miettinen H. A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care 1996; 19:1138-41.
21. Chan J M, Rimm E B, Colditz G A, Stampfer M J, Willett W C. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994; 17:961-9.
22. Barter P J, Rye K A. High density lipoproteins and coronary heart disease. Atherosclerosis 1996; 121:1-12.
23. Austin M A. Plasma triglyceride and coronary heart disease. Arterioscler Thromb Vasc Biol 1991; 11:2.
24. Austin M A, Breslow J L, Hennekens C H, Buring J E, Willet W C, Krauss R M. Low density lipoprotein subclass and risk of myocardial infarction. JAMA 1988; 260:1917-21.
25. Griffin B, Freeman D, Tait G, Thomson J, Caslake M, Packard C, et al. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: Relative contribution of small, dense LDL to coronary artery disease. Atherosclerosis 1994; 106:241-53.
26. Pouliot M C, Despres J P, Lemieux S, Moorjani S, Bouchard C, Tremblay A, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994; 73:460-8.
27. Young T K, Gelskey DE. Is noncentral obesity metabolically benign? Implications for prevention from a population survey. JAMA 1995; 274:1939-41.